The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast, and West Coast.

Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.